Company Profile
Inogen Stock Price, News & Analysis
- Ticker:
- INGN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
6.41 USD (+1.26%)
Close
Last updated: July 15, 2026 at 00:00
177.07M USD
Market cap
Why the stock is moving
INGN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Inogen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Inogen is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Inogen follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Inogen sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
ALNY · Source: Alnylam Pharmaceuticals, Inc.
- 04
GSK completes acquisition of Nuvalent, Inc.
GSK · Source: GSK plc
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Inogen (INGN)?
Inogen (INGN) most recently closed at 6.41 USD, a +1.26% move versus the previous session.
What is the market cap of Inogen (INGN)?
Inogen currently has a market capitalization of 177.07M USD on BioPharmSignal.
What does Inogen do?
Inogen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is INGN stock listed?
Inogen (INGN) is associated with NASDAQ, United States, Biotechnology.
What is Inogen?
Inogen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Inogen targeting with Inogen?
Inogen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.